journal
MENU ▼
Read by QxMD icon Read
search

Journal of the American Academy of Dermatology

journal
https://www.readbyqxmd.com/read/30031145/journal-of-the-american-academy-of-dermatology-original-article-comorbidities-in-alopecia-areata-a-systematic-review-and-meta-analysis
#1
Solam Lee, Hanil Lee, Chung Hyeok Lee, Won-Soo Lee
BACKGROUND: Alopecia areata (AA) may be associated with various systemic diseases according to several studies. OBJECTIVE: To identify prevalent and incident diseases in AA patients and quantify their prevalence and odds and hazard ratio compared with those in non-AA controls. METHODS: A systematic review of the studies published before February 28, 2018 was performed using MEDLINE, Embase, Web of Science and Cochrane Library databases. Observational studies on prevalent or incident diseases in AA patients were included, whereas studies limited to pediatrics or providing only laboratory results or continuous data were excluded...
July 18, 2018: Journal of the American Academy of Dermatology
https://www.readbyqxmd.com/read/30031144/long-term-sheltering-mustaches-reduce-incidence-of-lower-lip-actinic-keratosis
#2
Deede Y Liu, Muhammad I Gul, Jo Wick, Anand N Rajpara, Prescilia Isedeh, Ting Wang, Daniel J Aires
No abstract text is available yet for this article.
July 18, 2018: Journal of the American Academy of Dermatology
https://www.readbyqxmd.com/read/30025829/bullous-disorders-associated-with-anti-pd-1-and-anti-pd-l1-therapy-a-retrospective-analysis-evaluating-the-clinical-and-histopathologic-features-frequency-and-impact-on-cancer-therapy
#3
Jacob Siegel, Mariam Totonchy, William Damsky, Juliana Berk-Krauss, Frank Castiglione, Mario Sznol, Daniel P Petrylak, Neal Fischbach, Sarah B Goldberg, Roy H Decker, Angeliki M Stamatouli, Navid Hafez, Earl J Glusac, Mary M Tomayko, Jonathan S Leventhal
BACKGROUND: Bullous disorders associated with anti-PD-1/PD-L1 therapy are increasingly reported and may pose distinct therapeutic challenges. Their frequency and impact on cancer therapy are not well established. OBJECTIVE: To evaluate the clinical and histopathologic findings, frequency, and impact on cancer therapy of bullous eruptions due to anti-PD-1/PD-L1 therapy. METHODS: We retrospectively reviewed the medical records of patients evaluated by the onco-dermatology clinic and consultative service of Yale New Haven Hospital from 2016 to 2018...
July 16, 2018: Journal of the American Academy of Dermatology
https://www.readbyqxmd.com/read/30025828/femoral-artery-ultrasound-for-improving-the-detection-of-atherosclerosis-in-psoriasis
#4
Alvaro Gonzalez-Cantero, Jorge Gonzalez-Cantero, Ana Isabel Sanchez-Moya, Cristina Perez-Hortet, Salvador Arias-Santiago, Jose Luis Martin-Rodriguez, Cristina Schoendorff-Ortega, Jorge Luis Gonzalez-Calvin
No abstract text is available yet for this article.
July 16, 2018: Journal of the American Academy of Dermatology
https://www.readbyqxmd.com/read/30025827/less-painful-and-effective-intralesional-injection-method-for-lichen-simplex-chronicus
#5
Han Mi Jung, Sung Hye Eun, Ji Hae Lee, Gyong Moon Kim, Jung Min Bae
No abstract text is available yet for this article.
July 16, 2018: Journal of the American Academy of Dermatology
https://www.readbyqxmd.com/read/30025826/early-stage-melanoma-and-hematopoietic-stem-cell-transplantation-outcomes
#6
Charles J Puza, Paul J Mosca, Adela R Cardones
No abstract text is available yet for this article.
July 16, 2018: Journal of the American Academy of Dermatology
https://www.readbyqxmd.com/read/30012373/the-role-of-sunscreen-in-the-prevention-of-cutaneous-melanoma-and-non-melanoma-skin-cancer
#7
EDITORIAL
Reid A Waldman, Jane M Grant-Kels
No abstract text is available yet for this article.
July 13, 2018: Journal of the American Academy of Dermatology
https://www.readbyqxmd.com/read/30009865/sun-protection-behaviour-after-diagnosis-of-high-risk-primary-melanoma-and-risk-of-a-subsequent-primary
#8
Lena A von Schuckmann, Louise F Wilson, Maria Celia B Hughes, Vanessa L Beesley, Monika Janda, Jolieke C van der Pols, B Mark Smithers, Kiarash Khosrotehrani, Adele C Green
BACKGROUND: Melanoma survivors are at high risk of further primary melanomas. OBJECTIVE: To assess sun behaviour after melanoma diagnosis and in relation to further primary melanomas. METHODS: We applied repeated measures latent class analysis to reported primary prevention behaviour at time of diagnosis and six-monthly for two years post-diagnosis in patients with clinical stage IB-II melanoma. Correlates of behaviour trajectories and risk of subsequent primaries were determined using multivariable logistic and Cox-regression analyses, respectively...
July 12, 2018: Journal of the American Academy of Dermatology
https://www.readbyqxmd.com/read/30009864/second-primary-melanomas-increased-risk-and-decreased-time-to-presentation-in-patients-exposed-to-tanning-beds
#9
Yang Li, Mukti Kulkarni, Kathryn Trinkaus, Lynn A Cornelius
BACKGROUND: Melanoma incidence has increased; the primary modifiable risk factor is ultraviolet radiation (UVR) from the sun or artificial (arUVR) from tanning beds. OBJECTIVE: To determine whether certain characteristics distinguish patients who developed melanoma following arUVR. METHODS: A retrospective study of 434 melanoma patients was performed. Patients were consented at initial appointment and completed a questionnaire regarding phenotypic traits, medical history, and UVR exposure...
July 12, 2018: Journal of the American Academy of Dermatology
https://www.readbyqxmd.com/read/30017706/cme-part-ii-psoriasis-which-therapy-for-which-patient-focus-on-special-populations-and-chronic-infections
#10
REVIEW
Shivani B Kaushik, Mark G Lebwohl
Despite the availability of several new systemic agents for psoriasis treatment, it can be challenging to choose the right therapy in certain patient populations. There are few up-to-date reviews on systemic drugs for moderate to severe psoriasis in pregnant and pediatric patients and in patients with concomitant chronic infections such as hepatitis, HIV and latent tuberculosis. These groups are usually excluded from clinical trials and much of the available evidence is based on anecdotal case reports and case series...
July 11, 2018: Journal of the American Academy of Dermatology
https://www.readbyqxmd.com/read/30017705/cme-part-i-psoriasis-which-therapy-for-which-patient-psoriasis-comorbidities-and-preferred-systemic-agents
#11
REVIEW
Shivani B Kaushik, Mark G Lebwohl
Psoriasis is a systemic inflammatory disease associated with increased risk of comorbidities such as psoriatic arthritis, Crohn disease, malignancy, obesity and cardiovascular diseases. All these factors have a significant impact on the decision to use one therapy over another. The past decade has seen a paradigm shift in our understanding of the pathogenesis of psoriasis which has led to identification of new therapeutic targets. Several new drugs have gained FDA approval, expanding the psoriasis armamentarium but still a large number of patients continue to be untreated or undertreated...
July 11, 2018: Journal of the American Academy of Dermatology
https://www.readbyqxmd.com/read/30003993/antiandrogen-therapy-with-spironolactone-for-the-treatment-of-hidradenitis-suppurativa
#12
Nicole M Golbari, Martina L Porter, Alexa B Kimball
BACKGROUND: Hormonal therapy is a potential treatment for hidradenitis suppurativa (HS). However, little data exists describing the efficacy of spironolactone in HS treatment. OBJECTIVE: To assess whether spironolactone treatment improves HS disease severity and patient reported pain. METHODS: We performed a single center chart review of female HS patients treated with spironolactone between 2000 and 2017. Primary outcome measurements included the HS Physician Global Assessment (HSPGA), Hurley Staging, inflammatory lesion count, fistula count, and a numeric rating scale for pain...
July 9, 2018: Journal of the American Academy of Dermatology
https://www.readbyqxmd.com/read/30003992/pigmentation-of-basal-cell-carcinoma-is-inversely-associated-with-tumor-aggressiveness-in-asian-patients
#13
Hye-Rim Moon, Tae Jun Park, Ki Woong Ro, Hwa Jung Ryu, Soo Hong Seo, Sang Wook Son, Il-Hwan Kim
No abstract text is available yet for this article.
July 9, 2018: Journal of the American Academy of Dermatology
https://www.readbyqxmd.com/read/30003991/ustekinumab-treatment-for-neutrophilic-dermatoses-associated-with-crohn-s-disease-a-multicenter-retrospective-study
#14
Tullia de Risi-Pugliese, Philippe Seksik, Jean-David Bouaziz, François Chasset, Philippe Moguelet, Jean-Marc Gornet, Anne Bourrier, Aurélien Amiot, Laurent Beaugerie, Camille Francès, Sarah Guégan
No abstract text is available yet for this article.
July 9, 2018: Journal of the American Academy of Dermatology
https://www.readbyqxmd.com/read/30003990/methotrexate-for-alopecia-areata-a-systematic-review-and-meta-analysis
#15
Kevin Phan, Vignesh Ramachandran, Deshan Frank Sebaratnam
BACKGROUND: Methotrexate has been used both as an adjunct for low-risk maintenance therapy after initiation with corticosteroids for alopecia areata (AA) and as standalone therapy in some investigations, based on a lack of definitive evidence/guidelines. OBJECTIVE: To (1) determine the efficacy and risks associated with methotrexate therapy for AA (2) determine differences efficacy of combination with corticosteroids versus standalone treatment, and (3) determine relative efficacy of methotrexate in adult versus pediatric populations...
July 9, 2018: Journal of the American Academy of Dermatology
https://www.readbyqxmd.com/read/30003989/beyond-jaad-october-2018
#16
REVIEW
Andrew Bronin, Robert Phelps, Robert Sidbury
No abstract text is available yet for this article.
July 9, 2018: Journal of the American Academy of Dermatology
https://www.readbyqxmd.com/read/30003988/topical-glycopyrronium-tosylate-for-the-treatment-of-primary-axillary-hyperhidrosis-results-from-the-atmos-1-and-atmos-2-phase-3-randomized-controlled-trials
#17
Dee Anna Glaser, Adelaide A Hebert, Alexander Nast, William P Werschler, Lawrence Green, Richard Mamelok, Janice Drew, John Quiring, David M Pariser
BACKGROUND: Glycopyrronium tosylate (GT) is a topical anticholinergic developed for once-daily treatment of primary axillary hyperhidrosis. OBJECTIVE: Assess the efficacy and safety of GT for primary axillary hyperhidrosis. METHODS: ATMOS-1 and ATMOS-2 were replicate randomized, double-blind, vehicle-controlled, 4-week phase 3 trials. Patients were randomized 2:1 to GT 3.75% or vehicle applied once daily to each axilla for 4 weeks. Coprimary endpoints were responder rate (≥4-point improvement from Baseline) on Item 2 (sweating severity) of the Axillary Sweating Daily Diary (ASDD), a newly developed patient-reported outcome, and absolute change from Baseline in axillary gravimetric sweat production at Week 4...
July 9, 2018: Journal of the American Academy of Dermatology
https://www.readbyqxmd.com/read/30003987/the-alt-70-predictive-model-outperforms-thermal-imaging-for-the-diagnosis-of-lower-extremity-cellulitis-a-prospective-evaluation
#18
David G Li, Anna K Dewan, Fan Di Xia, Hasan Khosravi, Cara Joyce, Arash Mostaghimi
BACKGROUND: We previously demonstrated dermatology consultation to substantially reduce cellulitis misdiagnosis rates; however, broad implementation is impractical due to existing practice patterns and reimbursement systems. Meanwhile, efforts to improve diagnostic accuracy have culminated in point-of-care tools, including the ALT-70 predictive model for lower extremity cellulitis and thermal imaging. OBJECTIVE: To prospectively evaluate the performance of ALT-70 and thermal imaging in diagnosing lower extremity cellulitis in a head-to-head comparison...
July 9, 2018: Journal of the American Academy of Dermatology
https://www.readbyqxmd.com/read/30003986/mohs-micrographic-surgery-mms-with-mart-1-immunostaining-for-atypical-intraepidermal-melanocytic-proliferation-aimp
#19
Jeremy R Etzkorn, Olivia S Jew, Thuzar M Shin, Joseph F Sobanko, Donald E Neal, Christopher J Miller
BACKGROUND: The efficacy of Mohs micrographic surgery (MMS) for atypical intraepidermal melanocytic proliferation (AIMP) is unknown. OBJECTIVE: To ascertain the frequency of diagnostic change to melanoma (upstaging) and the frequency of local recurrence after MMS for AIMP. A secondary outcome was the frequency of subclinical spread (defined as the requirement for greater than one stage of MMS to achieve tumor-free margins). METHODS: Retrospective, cross-sectional study of 223 AIMP (with 92...
July 9, 2018: Journal of the American Academy of Dermatology
https://www.readbyqxmd.com/read/30003985/surgical-pearl-a-granny-sliding-knot-for-high-tension-closures
#20
Jeffrey F Scott, Mona Ascha, Whitney Pollard, Jeremy S Bordeaux
No abstract text is available yet for this article.
July 9, 2018: Journal of the American Academy of Dermatology
journal
journal
20132
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"